<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="pmd" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">pmd</book-part-id>
      <title-group>
        <title>
<italic toggle="yes">PLP1</italic>-Related Disorders</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hobson</surname>
            <given-names>Grace M</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Nemours Biomedical Research <break/>AI duPont Hospital for Children <break/>Wilmington, Delaware</aff>
          <email>ghobson@nemours.org</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kamholz</surname>
            <given-names>John</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Wayne State University School of Medicine<break/>Detroit, Michigan</aff>
          <email>jkamholz@med.wayne.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="1999-06-15" date-type="created">
          <day>15</day>
          <month>6</month>
          <year>1999</year>
        </date>
        <date iso-8601-date="2013-02-28" date-type="updated">
          <day>28</day>
          <month>2</month>
          <year>2013</year>
        </date>
        <date iso-8601-date="2004-10-07" date-type="revised">
          <day>7</day>
          <month>10</month>
          <year>2004</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="inad" document-type="chapter"><italic toggle="yes">PLA2G6</italic>-Associated Neurodegeneration</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="cdg-1a" document-type="chapter">PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>)</related-object>
      <abstract id="pmd.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">PLP1</italic>-related disorders of central nervous system myelin formation include a range of phenotypes from Pelizaeus-Merzbacher disease (PMD) to spastic paraplegia 2 (SPG2). PMD typically manifests in infancy or early childhood with nystagmus, hypotonia, and cognitive impairment; the findings progress to severe spasticity and ataxia. Life span is shortened. SPG2 manifests as spastic paraparesis with or without CNS involvement and usually normal life span. Intrafamilial variation of phenotypes can be observed, but the signs are usually fairly consistent within families. Female carriers may manifest mild to moderate signs of the disease.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Clinical diagnosis of <italic toggle="yes">PLP1</italic>-related disorders depends on typical neurologic findings, X-linked inheritance pattern, and, usually, the finding of diffusely abnormal myelin on MRI.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> A multidisciplinary team comprising specialists in neurology, physical medicine, orthopedics, pulmonary medicine, and gastroenterology should be assembled. Treatment may include gastrostomy for individuals with severe dysphagia; antiepileptic drugs (AEDs) for seizures; and routine management of spasticity including physical therapy, exercise, medications (baclofen, diazepam, tizanidine, botulinum toxin), orthotics, and surgery for joint contractures. Individuals with scoliosis benefit from proper wheelchair seating and physical therapy; surgery may be required in severe cases. Specialized education and assessments are generally necessary, and assisted communication devices may be helpful.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Proper wheelchair seating and physical therapy may help prevent scoliosis.</p>
          <p><italic toggle="yes">Surveillance</italic>: Semiannual to annual neurologic and physical medicine evaluations during childhood to monitor developmental progress, spasticity, and orthopedic complications.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">PLP1</italic>-related disorders are inherited in an X-linked manner. <italic toggle="yes">De novo</italic> pathogenic variants have been reported. Males with the PMD phenotype do not reproduce; males with the SPG2 phenotype may reproduce. All daughters of a male proband will be carriers; no sons will inherit the pathogenic variant. All sons of a female carrier are at a 50% risk of inheriting the pathogenic variant and having the disease; all daughters are at a 50% risk of being carriers. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible in families in which the <italic toggle="yes">PLP1</italic> pathogenic variant has been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="pmd.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="pmd.Tc" position="anchor" orientation="portrait">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_pmd.Tc_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">PLP1-</italic>Related Disorders: Included Phenotypes</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_pmd.Tc_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Pelizaeus-Merzbacher disease (PMD)</p>
                    </list-item>
                    <list-item>
                      <p>Spastic paraplegia 2 (SPG 2)</p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="pmd.Nomenclature">Nomenclature</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="pmd.Diagnosis">
        <title>Diagnosis</title>
        <sec id="pmd.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The <italic toggle="yes">PLP1</italic>-related disorders span a continuum of neurologic findings from Pelizaeus-Merzbacher disease (PMD) with severe CNS involvement to spastic paraparesis (SPG2). Intrafamilial variation of phenotypes can be observed, but the signs are usually fairly consistent within families.</p>
          <p><xref ref-type="bibr" rid="pmd.REF.boulloche.1986.233">Boulloche &#x00026; Aicardi [1986]</xref>, <xref ref-type="bibr" rid="pmd.REF.hodes.1993.383">Hodes et al [1993]</xref>, and <xref ref-type="bibr" rid="pmd.REF.cailloux.2000.837">Cailloux et al [2000]</xref> have summarized the clinical features of their series of individuals with PMD. The phenotypes in this spectrum cannot be neatly categorized into distinct syndromes but are summarized using designations frequently encountered in the medical literature (<xref ref-type="table" rid="pmd.T.spectrum_of_plp1related_disorders">Table 1</xref>).</p>
          <table-wrap id="pmd.T.spectrum_of_plp1related_disorders" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Spectrum of <italic toggle="yes">PLP1</italic>-Related Disorders</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Phenotype</th>
                  <th id="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Age of Onset</th>
                  <th id="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Neurologic&#x000a0;Findings</th>
                  <th id="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Ambulation</th>
                  <th id="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Speech</th>
                  <th id="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_6" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Age at Death</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Severe &#x02018;connatal&#x02019; PMD<hr/></td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Neonatal period<hr/></td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <list list-type="bullet">
                      <list-item>
                        <p>Nystagmus at birth</p>
                      </list-item>
                      <list-item>
                        <p>Pharyngeal&#x000a0;weakness</p>
                      </list-item>
                      <list-item>
                        <p>Stridor</p>
                      </list-item>
                      <list-item>
                        <p>Hypotonia</p>
                      </list-item>
                      <list-item>
                        <p>Severe spasticity</p>
                      </list-item>
                      <list-item>
                        <p>&#x000b1; Seizures</p>
                      </list-item>
                      <list-item>
                        <p>Cognitive impairment</p>
                      </list-item>
                    </list>
                    <hr/>
                  </td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Never achieved<hr/></td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Absent, but nonverbal communication and speech comprehension are possible<hr/></td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Infancy to 3<sup>rd</sup> decade<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Classic PMD<hr/></td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">First 5 years<hr/></td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <list list-type="bullet">
                      <list-item>
                        <p>Nystagmus in first 2 mos</p>
                      </list-item>
                      <list-item>
                        <p>Initial hypotonia</p>
                      </list-item>
                      <list-item>
                        <p>Spastic quadriparesis</p>
                      </list-item>
                      <list-item>
                        <p>Ataxia titubation</p>
                      </list-item>
                      <list-item>
                        <p>&#x000b1; Dystonia, athetosis</p>
                      </list-item>
                      <list-item>
                        <p>Cognitive impairment</p>
                      </list-item>
                    </list>
                    <hr/>
                  </td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">With assistance if achieved; lost in childhood / adolescence<hr/></td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Usually present<hr/></td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">3<sup>rd</sup>-7<sup>th</sup> decade<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">PLP1</italic> null syndrome<hr/></td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">First 5 years<hr/></td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <list list-type="bullet">
                      <list-item>
                        <p>No nystagmus</p>
                      </list-item>
                      <list-item>
                        <p>Mild spastic quadriparesis</p>
                      </list-item>
                      <list-item>
                        <p>Ataxia</p>
                      </list-item>
                      <list-item>
                        <p>Peripheral neuropathy</p>
                      </list-item>
                      <list-item>
                        <p>Mild to mod cognitive impairment</p>
                      </list-item>
                    </list>
                    <hr/>
                  </td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Present<hr/></td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Present; usually worsens after adolescence<hr/></td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">5<sup>th</sup>-7<sup>th</sup> decade<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Complicated spastic paraplegia (SPG2)<hr/></td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">First 5 years<hr/></td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <list list-type="bullet">
                      <list-item>
                        <p>Nystagmus</p>
                      </list-item>
                      <list-item>
                        <p>Ataxia</p>
                      </list-item>
                      <list-item>
                        <p>Autonomic dysfunction&#x000a0;<sup>1</sup></p>
                      </list-item>
                      <list-item>
                        <p>Spastic gait</p>
                      </list-item>
                      <list-item>
                        <p>Little or no cognitive impairment</p>
                      </list-item>
                    </list>
                    <hr/>
                  </td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Present<hr/></td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Present<hr/></td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">4<sup>th</sup>-7<sup>th</sup> decade<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Uncomplicated spastic paraplegia (SPG2)</td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Usually first 5 years; may be 3<sup>rd</sup>-4<sup>th</sup> decade</td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <list list-type="bullet">
                      <list-item>
                        <p>Autonomic&#x000a0;dysfunction&#x000a0;<sup>1</sup></p>
                      </list-item>
                      <list-item>
                        <p>Spastic gait</p>
                      </list-item>
                      <list-item>
                        <p>Normal cognition</p>
                      </list-item>
                    </list>
                  </td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Present</td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Present</td>
                  <td headers="hd_h_pmd.T.spectrum_of_plp1related_disorders_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Normal</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="pmd.TF.1.1">
                <label>1. </label>
                <p>Spastic urinary bladder</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <sec id="pmd.Imaging_Studies">
            <title>Imaging Studies</title>
            <p><bold>Magnetic resonance imaging (MRI)</bold> is most helpful in establishing the diagnosis in those who have CNS involvement [<xref ref-type="bibr" rid="pmd.REF.nezu.1998.334">Nezu et al 1998</xref>]:</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>PMD.</bold> Virtually all children with the PMD phenotype have a diffuse leukoencephalopathy, best appreciated on T<sub>2</sub>-weighted or fluid-attenuated inversion recovery (FLAIR) scans. These scans show diffusely increased signal intensity in the central white matter of the cerebral hemispheres, cerebellum, and brain stem. In most children, the amount of white matter is reduced in volume and can be readily seen as thinness of the corpus callosum or general decrease in myelination [<xref ref-type="bibr" rid="pmd.REF.plecko.2003.127">Plecko et al 2003</xref>]. Because the bulk of myelination normally occurs during the first two years of life, the T<sub>2</sub>-weighted MRI images may not show definitive abnormalities until a child is at least age one or two years. However, a normal newborn should have myelination-related T<sub>1</sub> and T<sub>2</sub> signal changes in the pons and cerebellum, and a normal three-month-old infant should have evidence of myelination in the posterior limb of the internal capsule, in the splenium of the corpus callosum, and in optic radiations [<xref ref-type="bibr" rid="pmd.REF.barkovich.2005.311">Barkovich 2005</xref>]. Absence of these early changes should raise the consideration for PMD or other dysmyelinating disorders.</p>
              </list-item>
              <list-item>
                <p><bold>SPG2.</bold> People with the SPG2 phenotype show less severe abnormalities on MRI scanning; they may have patchy abnormalities on T<sub>2</sub>-weighted scans or more diffuse leukoencephalopathy [<xref ref-type="bibr" rid="pmd.REF.hodes.1999.132">Hodes et al 1999</xref>].</p>
              </list-item>
            </list>
            <p><bold>Magnetic resonance spectroscopy (MRS)</bold> may show reduced white matter N-acetyl aspartate (NAA) levels, especially in individuals with the <italic toggle="yes">PLP1</italic> null syndrome [<xref ref-type="bibr" rid="pmd.REF.bonavita.2001.785">Bonavita et al 2001</xref>, <xref ref-type="bibr" rid="pmd.REF.garbern.2002.1033">Garbern &#x00026; Hobson 2002</xref>, <xref ref-type="bibr" rid="pmd.REF.plecko.2003.127">Plecko et al 2003</xref>]. In contrast, individuals with <italic toggle="yes">PLP1</italic> duplications may have increased white matter NAA levels and may be misdiagnosed with <related-object link-type="booklink" source-id="gene" document-id="canavan" document-type="chapter">Canavan disease</related-object> [<xref ref-type="bibr" rid="pmd.REF.takanashi.2002.237">Takanashi et al 2002</xref>]. The pattern of metabolite abnormalities in individuals with <italic toggle="yes">PLP1</italic> duplication appears distinctive &#x02014; with increased levels of glutamine, inositol, and creatine as well as of NAA &#x02014; and may assist in the discrimination of PMD from other leukodystrophies and demyelinating diseases [<xref ref-type="bibr" rid="pmd.REF.hanefeld.2005.701">Hanefeld et al 2005</xref>].</p>
          </sec>
        </sec>
        <sec id="pmd.Testing">
          <title>Testing</title>
          <p><bold>Cytogenetic analysis.</bold> Fewer than 1% of individuals with clinical features of PMD have interstitial duplications or more complex rearrangements of the X chromosome visible on routine cytogenetic studies [<xref ref-type="bibr" rid="pmd.REF.hodes.2000.14">Hodes et al 2000</xref>].</p>
          <sec id="pmd.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Gene.</bold>
<italic toggle="yes">PLP1</italic>-related disorders are caused by mutation of <italic toggle="yes">PLP1</italic>.</p>
            <p>
              <bold>Clinical testing</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>
                  <bold>Duplications</bold>
                </p>
                <list list-type="bullet">
                  <list-item>
                    <p>The majority of gene dosage changes are typically tandem duplications occurring in Xq22, which include the entire <italic toggle="yes">PLP1</italic>. In rare instances, the duplicated region can be inserted at some distance from Xq22; four insertions have been reported: at Xp22, Xq28 [<xref ref-type="bibr" rid="pmd.REF.woodward.1998a.a394">Woodward et al 1998a</xref>, <xref ref-type="bibr" rid="pmd.REF.hodes.2000.14">Hodes et al 2000</xref>], and 19qtel [<xref ref-type="bibr" rid="pmd.REF.inoue.2002a.838">Inoue et al 2002a</xref>], and in the Y chromosome [<xref ref-type="bibr" rid="pmd.REF.woodward.2005.966">Woodward et al 2005</xref>].</p>
                  </list-item>
                  <list-item>
                    <p>Triplication, partial triplication, and quintuplication of <italic toggle="yes">PLP1</italic> also occur [<xref ref-type="bibr" rid="pmd.REF.woodward.1998a.a394">Woodward et al 1998a</xref>, <xref ref-type="bibr" rid="pmd.REF.boespflugtanguy.1994.461">Boespflug-Tanguy et al 1994</xref>, <xref ref-type="bibr" rid="pmd.REF.wolf.2005.743">Wolf et al 2005</xref>, <xref ref-type="bibr" rid="pmd.REF.combes.2006.31">Combes et al 2006</xref>].</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p>
                  <bold>Deletions</bold>
                </p>
                <list list-type="bullet">
                  <list-item>
                    <p>Whole-gene deletions of <italic toggle="yes">PLP1</italic> occur in fewer than 2% of those with the Pelizaeus-Merzbacher disease phenotype [<xref ref-type="bibr" rid="pmd.REF.raskind.1991.1355">Raskind et al 1991</xref>; <xref ref-type="bibr" rid="pmd.REF.boespflugtanguy.1994.461">Boespflug-Tanguy et al 1994</xref>; <xref ref-type="bibr" rid="pmd.REF.inoue.2002a.838">Inoue et al 2002a</xref>; Shaffer, unpublished observations]. <xref ref-type="bibr" rid="pmd.REF.inoue.2002a.838">Inoue et al [2002a]</xref> determined that the individual originally described with a <italic toggle="yes">PLP1</italic> deletion has a complex rearrangement with both a deletion of <italic toggle="yes">PLP1</italic> and an inverted insertion of a more distal portion of the X chromosome at the deletion junction. In addition, this individual has duplication of a region distal of <italic toggle="yes">PLP1</italic> [<xref ref-type="bibr" rid="pmd.REF.hobson.2002b.2045a">Hobson et al 2002b</xref>, <xref ref-type="bibr" rid="pmd.REF.lee.2007.1235">Lee et al 2007</xref>].</p>
                  </list-item>
                  <list-item>
                    <p>Partial <italic toggle="yes">PLP1</italic> deletion has also been reported [<xref ref-type="bibr" rid="pmd.REF.combes.2006.31">Combes et al 2006</xref>].</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p><bold>Position effect rearrangements,</bold> chromosomal rearrangements that place genes under the control of heterologous regulatory elements, appear to account for a very small proportion of PMD and SPG2:</p>
                <list list-type="bullet">
                  <list-item>
                    <p>Disruption of regulatory elements of a gene neighboring <italic toggle="yes">PLP1</italic> resulting in dysregulation of <italic toggle="yes">PLP1</italic> expression through position effect was proposed as the explanation for a PMD-like syndrome in a child in whom conventional chromosome analysis identified an inversion of the X chromosome with a breakpoint near (70 kbp) but not including <italic toggle="yes">PLP1</italic> [<xref ref-type="bibr" rid="pmd.REF.muncke.2004.e121">Muncke et al 2004</xref>].</p>
                  </list-item>
                  <list-item>
                    <p>Position effect of a duplication identified by FISH that was near but did not include <italic toggle="yes">PLP1</italic> has been invoked as the cause of the neurologic syndrome in a man with spastic paraplegia [<xref ref-type="bibr" rid="pmd.REF.lee.2006.398">Lee et al 2006</xref>].</p>
                  </list-item>
                </list>
              </list-item>
            </list>
            <table-wrap id="pmd.T.summary_of_molecular_genetic_testi" position="anchor" orientation="portrait">
              <label>Table 2. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">PLP1</italic>-Related Disorders</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_1_2">Test Method</th>
                    <th id="hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_1_3">Variants Detected&#x000a0;<sup>2</sup></th>
                    <th id="hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Variant Detection Frequency by Test Method&#x000a0;<sup>3</sup><hr/></th>
                  </tr>
                  <tr>
                    <th headers="hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_1_4" id="hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Affected Males</th>
                    <th headers="hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_1_4" id="hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Carrier Females</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">PLP1</italic>
                    </td>
                    <td headers="hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">FISH and deletion/duplication analysis&#x000a0;<sup>4,&#x000a0;5</sup><hr/></td>
                    <td headers="hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Deletions/duplications<hr/></td>
                    <td headers="hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_1_4 hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">50%&#x000a0;<sup>6</sup><hr/></td>
                    <td headers="hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_1_4 hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">50%-75%<hr/></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis&#x000a0;<sup>7</sup></td>
                    <td headers="hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_1_4 hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">30%&#x000a0;<sup>8</sup></td>
                    <td headers="hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_1_4 hd_h_pmd.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">See footnote 9</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="pmd.TF.2.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="pmd" object-id="pmd.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="pmd.TF.2.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="pmd.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="pmd.TF.2.3">
                  <label>3. </label>
                  <p>The ability of the test method used to detect a variant that is present in the indicated gene. Approximately 20% of males with clinical findings consistent with <italic toggle="yes">PLP1</italic>-related disorders do not have an identifiable pathogenic variant in <italic toggle="yes">PLP1</italic>, suggesting that pathogenic variants may occur in regions of the gene not routinely analyzed, such as far upstream or downstream regions or introns.</p>
                </fn>
                <fn id="pmd.TF.2.4">
                  <label>4. </label>
                  <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
                <fn id="pmd.TF.2.5">
                  <label>5. </label>
                  <p>Published methods include <xref ref-type="bibr" rid="pmd.REF.gao.2005.466">Gao et al [2005]</xref>, <xref ref-type="bibr" rid="pmd.REF.h_bner.2005.321">H&#x000fc;bner et al [2005]</xref>, <xref ref-type="bibr" rid="pmd.REF.regis.2005.73">Regis et al [2005]</xref>, <xref ref-type="bibr" rid="pmd.REF.wolf.2005.743">Wolf et al [2005]</xref>, <xref ref-type="bibr" rid="pmd.REF.combes.2006.31">Combes et al [2006]</xref>, <xref ref-type="bibr" rid="pmd.REF.warshawsky.2006.1267">Warshawsky et al [2006]</xref>.</p>
                </fn>
                <fn id="pmd.TF.2.6">
                  <label>6. </label>
                  <p>Gene dosage changes of variable size are found in at least 50% of males with <italic toggle="yes">PLP1</italic>-related disorders [<xref ref-type="bibr" rid="pmd.REF.sistermans.1998.1749">Sistermans et al 1998</xref>, <xref ref-type="bibr" rid="pmd.REF.inoue.1999.624">Inoue et al 1999</xref>].</p>
                </fn>
                <fn id="pmd.TF.2.7">
                  <label>7. </label>
                  <p>Examples of pathogenic variants detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="pmd.TF.2.8">
                  <label>8. </label>
                  <p>While most single-nucleotide variants result in missense or frameshift changes, variants that affect splicing also occur, along with deletions and insertions that are smaller than a whole exon [<xref ref-type="bibr" rid="pmd.REF.sistermans.1998.1749">Sistermans et al 1998</xref>, <xref ref-type="bibr" rid="pmd.REF.hobson.2000.1089">Hobson et al 2000</xref>, <xref ref-type="bibr" rid="pmd.REF.hobson.2002a.477">Hobson et al 2002a</xref>, <xref ref-type="bibr" rid="pmd.REF.h_bner.2005.321">H&#x000fc;bner et al 2005</xref>, <xref ref-type="bibr" rid="pmd.REF.hobson.2006.69">Hobson et al 2006</xref>, <xref ref-type="bibr" rid="pmd.REF.wang.2006.999">Wang et al 2006</xref>]. Sequence analysis is generally performed only when a <italic toggle="yes">PLP1</italic> duplication is not detected. However, lack of amplification by PCR prior to sequence analysis can suggest a putative exon or whole-gene deletion in affected males.</p>
                </fn>
                <fn id="pmd.TF.2.9">
                  <label>9. </label>
                  <p>Sequence analysis of genomic DNA cannot detect (multi)exon or whole-gene deletions on the X chromosome in carrier females.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Interpretation of test results.</bold> Approximately 20% of males with clinical findings consistent with the <italic toggle="yes">PLP1</italic>-related disorders do not have identifiable pathogenic variants in <italic toggle="yes">PLP1</italic>, suggesting that pathogenic variants may occur in regions of the gene not routinely analyzed (e.g., far upstream or downstream regions or introns) or that they have another disorder that clinically resembles a <italic toggle="yes">PLP1</italic>-related disorder. See <xref ref-type="sec" rid="pmd.Differential_Diagnosis">Differential Diagnosis</xref>.</p>
          </sec>
        </sec>
        <sec id="pmd.Testing_Strategy">
          <title>Testing Strategy</title>
          <p>
            <bold>To confirm/establish the diagnosis in a proband</bold>
          </p>
          <list list-type="order">
            <list-item>
              <label>1</label>
              <p>Perform deletion/duplication analysis. Deletion/duplication analysis by CMA or other quantitative molecular method is sensitive and specific for detecting copy number variants.</p>
            </list-item>
            <list-item>
              <label>2</label>
              <p>If deletion/duplication analysis:</p>
              <list list-type="alpha-lower">
                <list-item>
                  <label>a</label>
                  <p>Identifies a copy number variant in an individual of high clinical suspicion, perform interphase FISH to determine if the duplication is a direct or an insertional event. Interphase FISH testing can identify the occasional instances in which the duplicated locus is inserted into heterologous loci, and can also identify instances of somatic mosaicism for the duplication. Note: Because the probes for FISH analysis are typically quite large (&#x0003e;40 kbp) and include sequences that lie outside of <italic toggle="yes">PLP1</italic>, which is approximately 20 kbp, it is possible that FISH testing may suggest <italic toggle="yes">PLP1</italic> duplication but actually detect duplication of regions flanking <italic toggle="yes">PLP1</italic> that do not involve <italic toggle="yes">PLP1</italic> itself [<xref ref-type="bibr" rid="pmd.REF.lee.2006.398">Lee et al 2006</xref>]. Therefore, direct dosage testing of <italic toggle="yes">PLP1</italic> itself, and not dosing of flanking sequences should be done if the clinical syndrome is typical of a <italic toggle="yes">PLP1</italic>-related disorder.</p>
                </list-item>
                <list-item>
                  <label>b</label>
                  <p>Does not identify a duplication or deletion, sequence <italic toggle="yes">PLP1</italic>.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Identification of female carriers</bold> is made by prior identification of the pathogenic variant in the family and testing for the specific variant.</p>
          <p>If an affected male is not available for testing:</p>
          <list list-type="order">
            <list-item>
              <label>1</label>
              <p>Perform deletion/duplication analysis.</p>
            </list-item>
            <list-item>
              <label>2</label>
              <p>If no deletion or duplication is identified, perform sequence analysis.</p>
            </list-item>
          </list>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variant in the family.</p>
        </sec>
      </sec>
      <sec id="pmd.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="pmd.Clinical_Description">
          <title>Clinical Description</title>
          <p>Pelizaeus-Merzbacher disease (PMD) and X-linked spastic paraplegia 2 (SPG2) are at opposite ends of a clinical spectrum of disease caused by pathogenic variants in <italic toggle="yes">PLP1</italic>, which results in defective central nervous system (CNS) myelination. PMD and SPG2 have been observed in different males within the same family [<xref ref-type="bibr" rid="pmd.REF.hodes.1993.383">Hodes et al 1993</xref>, <xref ref-type="bibr" rid="pmd.REF.sistermans.1998.1749">Sistermans et al 1998</xref>].</p>
          <p><bold>Severe or &#x02018;connatal&#x02019; PMD</bold> is apparent at birth or in the first few weeks of life. Findings include pendular nystagmus, hypotonia, pharyngeal weakness, and stridor. Seizures may develop in affected infants, and motor deficits are severe.</p>
          <p>Later, children with severe PMD may have short stature and poor weight gain. Hypotonia later evolves into spasticity of the extremities that is usually quite severe. Children do not walk or develop effective use of the upper limbs. Verbal expression is severely limited, but comprehension may be significant. Swallowing difficulties may require feeding tube placement.</p>
          <p>Affected children may die during infancy or childhood, usually of aspiration; with attentive care, they may live into the third decade or longer.</p>
          <p><bold>Classic PMD</bold> was originally described by <xref ref-type="bibr" rid="pmd.REF.pelizaeus.1885.698">Pelizaeus [1885]</xref> and <xref ref-type="bibr" rid="pmd.REF.merzbacher.1910.1">Merzbacher [1910]</xref>. Males with classic PMD usually develop nystagmus, which may not be recognized until several months of age; in rare cases, nystagmus does not develop. Affected children have hypotonia and develop titubation (tremor of the head and neck), ataxia, and spastic quadriparesis beginning in the first five years. They usually have some purposeful voluntary control of the arms. If acquired, ambulation usually requires assistive devices such as crutches or a walker; it is generally lost as spasticity increases during later childhood or adolescence.</p>
          <p>Cognitive abilities are impaired, but exceed those of the more severely affected children; language and speech usually develop. Extrapyramidal abnormalities, such as dystonic posturing and athetosis, may occur.</p>
          <p>Survival into the sixth or seventh decade has been observed.</p>
          <p><bold>A transitional form,</bold> intermediate in onset and severity to the connatal and classic forms of PMD, has also been defined.</p>
          <p><bold><italic toggle="yes">PLP1</italic> null syndrome</bold> is distinguished by the absence of nystagmus and the presence of relatively mild spastic quadriparesis that mostly affects the legs, with ataxia and mild multifocal demyelinating peripheral neuropathy. Those with the <italic toggle="yes">PLP1</italic> null syndrome generally ambulate better than those with classic PMD but may progress more rapidly because of degeneration of axons, inferred on the basis of magnetic resonance spectroscopy, which demonstrates reduced levels of white matter NAA [<xref ref-type="bibr" rid="pmd.REF.garbern.2002.551">Garbern et al 2002</xref>].</p>
          <p><bold>Complicated spastic paraparesis (SPG2)</bold> often includes autonomic dysfunction (e.g., spastic urinary bladder), ataxia, and nystagmus. A clear distinction cannot be drawn on objective criteria between complicated spastic paraplegia and relatively mild PMD (e.g., <italic toggle="yes">PLP1</italic> null syndrome).</p>
          <p><bold>Pure spastic paraparesis (SPG2)</bold> does not, by definition, include other significant CNS signs, although autonomic dysfunction, such as spastic urinary bladder, may also occur. Life span is normal.</p>
          <p>Males with SPG2 have reproduced; males with the PMD phenotype have not.</p>
          <sec id="pmd.Neurophysiologic_Studies">
            <title>Neurophysiologic Studies</title>
            <p>Visual, auditory, and somatosensory evoked potential testing show normal to near-normal latencies of the peripheral component of the respective sensory modality, but severely prolonged or absent central latencies.</p>
            <p>Except in families with <italic toggle="yes">PLP1</italic> null alleles or pathogenic variants affecting the <italic toggle="yes">PLP1</italic>-specific region or some splice site variants [<xref ref-type="bibr" rid="pmd.REF.shy.2003.354">Shy et al 2003</xref>, <xref ref-type="bibr" rid="pmd.REF.vaursbarri_re.2003.769">Vaurs-Barri&#x000e8;re et al 2003</xref>], peripheral nerve conduction studies are normal. When peripheral neuropathy is present, it is mild in comparison to the central nervous system disorder, and is characterized by mild slowing of conduction velocities that may be more pronounced across those regions of a limb susceptible to compression, such as the wrist and elbow.</p>
            <p><bold>Heterozygotes.</bold> Women with a <italic toggle="yes">PLP1</italic> pathogenic variant may or may not have symptoms. Several investigators have observed that in families with severely affected males, the heterozygous women are unlikely to have clinical manifestations of the <italic toggle="yes">PLP1</italic>-related disorders, whereas in families with mildly affected males, the heterozygous women are more likely to have symptoms [<xref ref-type="bibr" rid="pmd.REF.sivakumar.1999.680">Sivakumar et al 1999</xref>, <xref ref-type="bibr" rid="pmd.REF.hurst.2006.371">Hurst et al 2006</xref>]. Thus, an inverse relationship exists between the severity of manifestations in males and the likelihood of heterozygous females having neurologic signs.</p>
            <p>The risk to heterozygous females of developing neurologic signs is greatest in families in which affected males have a <italic toggle="yes">PLP1</italic> null syndrome, followed by those in which affected males have an SPG2 syndrome [<xref ref-type="bibr" rid="pmd.REF.hurst.2006.371">Hurst et al 2006</xref>]. The risk of developing neurologic signs is lowest with <italic toggle="yes">PLP1</italic> duplication heterozygotes, who usually have favorably skewed X-chromosome inactivation [<xref ref-type="bibr" rid="pmd.REF.woodward.2000.449">Woodward et al 2000</xref>].</p>
            <p>The following explanation is offered:</p>
            <list list-type="bullet">
              <list-item>
                <p>Alleles associated with a severe phenotype cause apoptosis (cell death) of oligodendrocytes (the cells that make myelin in the CNS) during early childhood. In heterozygous females, the oligodendrocytes that express the mutant <italic toggle="yes">PLP1</italic> allele on the active X chromosome undergo apoptosis early in life but are replaced over time by oligodendrocytes that express the normal <italic toggle="yes">PLP1</italic> allele on the active X chromosome. Thus, females who carry a severe <italic toggle="yes">PLP1</italic> pathogenic variant may develop neurologic signs because of skewed inactivation of the X chromosome with the normal <italic toggle="yes">PLP1</italic> allele (as with other X-linked recessive disorders) or may have transient signs (while the oligodendrocytes expressing the mutant <italic toggle="yes">PLP1</italic> are still present) that abate as the degenerating oligodendrocytes are replaced by those expressing the normal <italic toggle="yes">PLP1</italic> allele [<xref ref-type="bibr" rid="pmd.REF.inoue.2001.747">Inoue et al 2001</xref>].</p>
              </list-item>
              <list-item>
                <p>Alleles associated with a mild phenotype in males do not cause apoptosis of oligodendrocytes. In heterozygous females, abnormal oligodendrocytes persist and can cause neurologic signs [<xref ref-type="bibr" rid="pmd.REF.sivakumar.1999.680">Sivakumar et al 1999</xref>].</p>
              </list-item>
            </list>
            <p><xref ref-type="bibr" rid="pmd.REF.hurst.2006.371">Hurst et al [2006]</xref> analyzed families with SPG2 or PMD and provided statistical support for the inverse correlation between the severity of phenotypes in affected males and their heterozygous relatives. These observations have important implications for genetic counseling and are discussed in <xref ref-type="sec" rid="pmd.Risk_to_Family_Members">Risk to Family Members</xref>, <bold>Sibs of a male proband</bold>.</p>
            <p>Manifesting heterozygotes are usually not index cases, but rather are identified in the course of evaluating the relatives of an affected male.</p>
          </sec>
        </sec>
        <sec id="pmd.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Some genotype-phenotype correlations exist.</p>
          <p>Most individuals with <italic toggle="yes">PLP1</italic> duplications have classic PMD; however, some are classified as having connatal PMD and may have three or more copies of the <italic toggle="yes">PLP1</italic> locus [<xref ref-type="bibr" rid="pmd.REF.wolf.2005.743">Wolf et al 2005</xref>]. Variation in the extent of duplication or location(s) of the breakpoints or reinsertion sites may account for clinical variability.</p>
          <p>The most severe clinical syndromes are typically caused by missense variants (especially non-conservative amino acid substitutions) and other <italic toggle="yes">PLP1</italic> single-nucleotide variants or indels.</p>
          <p>The milder spastic paraplegia syndrome is most often caused by conservative amino acid substitutions in presumably less critical regions of the protein. The locations of these pathogenic variants do not provide a clear correlation between amino acid position and clinical phenotype. However, pathogenic variants in the <italic toggle="yes">PLP1</italic>-specific domain encoded by amino acid residues 117-151 tend to cause less severe syndromes [<xref ref-type="bibr" rid="pmd.REF.cailloux.2000.837">Cailloux et al 2000</xref>] (see <xref ref-type="sec" rid="pmd.Molecular_Genetics">Molecular Genetics</xref>).</p>
          <p>Although PMD has classically been regarded as a strictly central nervous system disorder, those with null <italic toggle="yes">PLP1</italic> variants, including deletion of <italic toggle="yes">PLP1</italic> [<xref ref-type="bibr" rid="pmd.REF.raskind.1991.1355">Raskind et al 1991</xref>], a frameshift variant, and a missense variant affecting the initiation codon do develop a relatively mild demyelinating peripheral neuropathy, demonstrating that myelin proteolipid protein (PLP1) and/or DM20 (an alternatively spliced transcript; see following paragraph and <xref ref-type="sec" rid="pmd.Molecular_Genetics">Molecular Genetics</xref>) does indeed function in the peripheral nervous system as well as in the central nervous system. Furthermore, the null phenotype has less severe CNS signs than those seen with the more typical forms of PMD. The null phenotype is associated with length-dependent degeneration of major central motor and sensory tracts and reduced levels of N-acetyl aspartate in cerebral white matter.</p>
          <p>Peripheral neuropathy as well as a relatively mild CNS syndrome results from pathogenic variants that affect only the <italic toggle="yes">PLP1</italic>-specific region [<xref ref-type="bibr" rid="pmd.REF.shy.2003.354">Shy et al 2003</xref>] (see <xref ref-type="sec" rid="pmd.Molecular_Genetics">Molecular Genetics</xref>). The CNS syndrome can be milder than that observed in individuals with the null phenotype.</p>
        </sec>
        <sec id="pmd.Penetrance">
          <title>Penetrance</title>
          <p><italic toggle="yes">PLP1</italic> pathogenic variants are believed to be completely penetrant in males. The complete conservation of amino acid sequence between rodent and human <italic toggle="yes">PLP1</italic> suggests that any variation from the normal sequence may be detrimental.</p>
        </sec>
        <sec id="pmd.Anticipation">
          <title>Anticipation</title>
          <p>Anticipation has not been reported for <italic toggle="yes">PLP1</italic> pathogenic variants.</p>
        </sec>
        <sec id="pmd.Nomenclature">
          <title>Nomenclature</title>
          <p>Pelizaeus-Merzbacher disease is also known as sudanophilic leukodystrophy.</p>
          <p>Proteolipid protein 1 was previously called proteolipid protein. After discovery of a similar gene that is predominantly expressed in gut, numerical designation was added.</p>
          <p>Note also that the older literature usually begins numbering of the amino acids with the glycine encoded by codon 2, since the initiation methionine is cleaved post-translationally.</p>
        </sec>
        <sec id="pmd.Prevalence">
          <title>Prevalence</title>
          <p>In the US, the prevalence of PMD in the population is estimated at 1:200,000 to 1:500,000.</p>
          <p>In a survey of leukodystrophies in Germany, the incidence of PMD was approximately 0.13:100,000 live births [<xref ref-type="bibr" rid="pmd.REF.heim.1997.475">Heim et al 1997</xref>].</p>
          <p><xref ref-type="bibr" rid="pmd.REF.seeman.2003.95">Seeman et al [2003]</xref> reported that in the Czech Republic <italic toggle="yes">PLP1</italic> pathogenic variants were detected in 1:90,000 births. While this may reflect a situation particular to the Czech Republic, it suggests that the prevalence of PMD may be higher than is generally recognized.</p>
        </sec>
      </sec>
      <sec id="pmd.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No other phenotypes are associated with mutation of <italic toggle="yes">PLP1</italic>.</p>
      </sec>
      <sec id="pmd.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Individuals with <italic toggle="yes">PLP1</italic>-related disorders are often initially diagnosed with cerebral palsy or static encephalopathy.</p>
        <sec id="pmd.PelizaeusMerzbacher_Disease_PMD">
          <title>Pelizaeus-Merzbacher Disease (PMD)</title>
          <p>The combination of nystagmus within the first two years of life, initial hypotonia, and abnormal white matter changes on the brain MRI (e.g., abnormal signal in the posterior limbs of the internal capsule, the middle, and superior cerebellar peduncles and the medial and lateral lemnisci, all of which should be myelinated in a normal newborn) should suggest the diagnosis of PMD, especially if the family history is consistent with an X-linked disorder. In a recent survey of children with inherited diseases of white matter identified by neuroimaging, 7.4% had PMD, the second most common cause of leukodystrophy [<xref ref-type="bibr" rid="pmd.REF.bonkowsky.2010.718">Bonkowsky et al 2010</xref>], suggesting that the disease is relatively common.</p>
          <p>Approximately 20% of males with clinical findings consistent with the <italic toggle="yes">PLP1</italic>-related disorders do not have identifiable pathogenic variants in <italic toggle="yes">PLP1</italic>. Although <italic toggle="yes">PLP1</italic> pathogenic variants that lie in non-coding regions not analyzed during clinical testing may be a potential cause, other loci account for similar clinical syndromes. Recently another X-linked syndrome with neonatal hypotonia, nystagmus, developmental delay, and diffuse hypomyelination was shown to be caused by mutation of <italic toggle="yes">SLC16A2</italic> (also known as <italic toggle="yes">MCT8</italic>) [<xref ref-type="bibr" rid="pmd.REF.vaursbarri_re.2009.114">Vaurs-Barri&#x000e8;re et al 2009</xref>]. See <related-object link-type="booklink" source-id="gene" document-id="thctd" document-type="chapter"><italic toggle="yes">MCT8 </italic>(<italic toggle="yes">SLC16A2</italic>)<italic toggle="yes">-</italic>Specific Thyroid Hormone Cell Transporter Deficiency</related-object>.</p>
          <p>Pathogenic variants in <italic toggle="yes">FAM126A</italic> (also called <italic toggle="yes">HYCC1, HCC,</italic> and <italic toggle="yes">DRCTNNB1A</italic>) cause an autosomal recessive syndrome characterized by the presence of congenital cataract, developmental delay, ataxia (which slowly progresses and is associated with diffuse leukodystrophy, often with areas with both T<sub>2</sub>-weighted hyperintensity and T<sub>1</sub>-weighted hypointensity, suggesting increased water content in those regions), and demyelinating peripheral neuropathy [<xref ref-type="bibr" rid="pmd.REF.biancheri.2007.121">Biancheri et al 2007</xref>].</p>
          <p>An autosomal recessive syndrome characterized by early-onset nystagmus, delayed motor milestones, ataxia, progressive spasticity, partial seizures, mild peripheral neuropathy, and diffuse leukodystrophy on MRI was found to be caused by pathogenic variants in <italic toggle="yes">GJC2</italic> (formerly <italic toggle="yes">GJA12</italic>), encoding connexin 46.6 [<xref ref-type="bibr" rid="pmd.REF.uhlenberg.2004.251">Uhlenberg et al 2004</xref>, <xref ref-type="bibr" rid="pmd.REF.bugiani.2006.273">Bugiani et al 2006</xref>, <xref ref-type="bibr" rid="pmd.REF.orthmannmurphy.2007.629">Orthmann-Murphy et al 2007</xref>, <xref ref-type="bibr" rid="pmd.REF.salviati.2007.57">Salviati et al 2007</xref>, <xref ref-type="bibr" rid="pmd.REF.wolf.2007.39">Wolf et al 2007</xref>, <xref ref-type="bibr" rid="pmd.REF.henneke.2008.748">Henneke et al 2008</xref>, <xref ref-type="bibr" rid="pmd.REF.sartori.2008.348">Sartori et al 2008</xref>, <xref ref-type="bibr" rid="pmd.REF.ruf.2009.226">Ruf &#x00026; Uhlenberg 2009</xref>].</p>
          <p>Another autosomal recessive syndrome has been described in an Israeli Bedouin family. The syndrome, which resembles severe PMD, is associated with acquired microcephaly and is caused by a pathogenic variant in <italic toggle="yes">HSPD1</italic> (formerly <italic toggle="yes">HSP60</italic>) [<xref ref-type="bibr" rid="pmd.REF.magen.2008.30">Magen et al 2008</xref>].</p>
          <p>Other leukodystrophies including <related-object link-type="booklink" source-id="gene" document-id="mld" document-type="chapter">metachromatic leukodystrophy</related-object>, <related-object link-type="booklink" source-id="gene" document-id="x-ald" document-type="chapter">X-linked adrenoleukodystrophy</related-object>, <related-object link-type="booklink" source-id="gene" document-id="krabbe" document-type="chapter">Krabbe disease</related-object>, and <related-object link-type="booklink" source-id="gene" document-id="canavan" document-type="chapter">Canavan disease</related-object> do not typically cause nystagmus, and the MRI usually shows a regional predilection of abnormality, e.g., occipital white matter in X-linked adrenoleukodystrophy and frontal white matter in metachromatic leukodystrophy. In these leukodystrophies, nerve conduction velocity (NCV) and evoked potentials are usually abnormal.</p>
          <p><related-object link-type="booklink" source-id="gene" document-id="cach" document-type="chapter">Childhood ataxia with central nervous system hypomyelination/vanishing white matter disease</related-object> (CACH/VWM) is an autosomal recessive disorder characterized by ataxia, spasticity, and variable optic atrophy [<xref ref-type="bibr" rid="pmd.REF.pronk.2006.123">Pronk et al 2006</xref>, <xref ref-type="bibr" rid="pmd.REF.scali.2006.271">Scali et al 2006</xref>, <xref ref-type="bibr" rid="pmd.REF.van_der_knaap.2006.413">van der Knaap et al 2006</xref>]. The phenotypic range includes a subacute infantile form (onset age &#x0003c;1 year), an early-childhood onset form (onset age 1-5 years), a late-childhood/juvenile-onset form (onset age 5-15 years), and an adult-onset form. Chronic progressive decline can be exacerbated by rapid deterioration during febrile illnesses or following head trauma. The diagnosis of CACH/VWM is based on clinical findings, characteristic abnormalities on cranial MRI, and identifiable pathogenic variants in one of five genes (<italic toggle="yes">EIF2B1</italic>, <italic toggle="yes">EIF2B2</italic>, <italic toggle="yes">EIF2B3</italic>, <italic toggle="yes">EIF2B4</italic>, and <italic toggle="yes">EIF2B5</italic>) encoding the five subunits of the eukaryotic translation initiation factor eIF2B [<xref ref-type="bibr" rid="pmd.REF.leegwater.2001.383">Leegwater et al 2001</xref>].</p>
          <p><related-object link-type="booklink" source-id="gene" document-id="alexander" document-type="chapter">Alexander disease</related-object> is an autosomal dominant disorder caused by mutation of <italic toggle="yes">GFAP</italic>, the gene encoding glial fibrillary acidic protein (reviewed in <xref ref-type="bibr" rid="pmd.REF.johnson.2002.391">Johnson [2002]</xref>). Affected individuals have developmental delay, progressive spasticity, cognitive impairment, and macrocephaly. MRI shows extensive T<sub>2</sub>-weighted hyperintensity especially in the frontal white matter, but with periventricular T<sub>1</sub>-weighted hyperintensity and T<sub>2</sub>-weighted hypointensity [<xref ref-type="bibr" rid="pmd.REF.van_der_knaap.2001.541">van der Knaap et al 2001</xref>].</p>
          <p>Infants with <related-object link-type="booklink" source-id="gene" document-id="cmd-overview" document-type="chapter">congenital muscular dystrophy</related-object> with merosin deficiency have markedly increased T<sub>2</sub> signal in the cerebral white matter. Severe weakness and hypotonia in the absence of nystagmus should direct the clinician toward consideration of myopathy [<xref ref-type="bibr" rid="pmd.REF.mercuri.1995.3">Mercuri et al 1995</xref>].</p>
          <p>An adult-onset, autosomal dominant leukodystrophy that clinically resembles progressive multiple sclerosis has been shown to be caused by duplication of <italic toggle="yes">LMNB1</italic>, which encodes lamin B1 [<xref ref-type="bibr" rid="pmd.REF.padiath.2006.1114">Padiath et al 2006</xref>]. See <related-object link-type="booklink" source-id="gene" document-id="lad-ad" document-type="chapter">Autosomal Dominant Leukodystrophy with Autonomic Disease</related-object>.</p>
          <p><related-object link-type="booklink" source-id="gene" document-id="arts" document-type="chapter">Arts syndrome</related-object>, caused by pathogenic variants in <italic toggle="yes">PRPS1</italic>, is an X-linked disorder characterized by profound congenital sensorineural hearing impairment, early-onset hypotonia, delayed motor development, mild to moderate intellectual disability, ataxia, and increased risk for infection. Onset of all findings (except optic atrophy) is before age two years. Signs of peripheral neuropathy develop during early childhood. The MRI does not show a pattern of leukodystrophy. Twelve of 15 boys from the two families reported with Arts syndrome died before age six years of complications of infection. Carrier females can show late-onset (age &#x0003e;20 years) hearing impairment and other findings.</p>
          <p>Some children with <related-object link-type="booklink" source-id="gene" document-id="issd" document-type="chapter">Salla disease</related-object> (free sialic acid storage disorders) may present with hypotonia, nystagmus, and delay of motor and cognitive abilities. Seizures are more common than in PMD, but children with Salla disease are more likely to show improvement. A broad range of clinical severity exists, from a syndrome characterized by permanent quadriparesis and failure to acquire speech that is usually fatal during childhood to a relatively mild form with delayed speech, delayed ambulation, mild intellectual disability, and normal life expectancy. In severely affected children, MRI shows diffusely abnormal myelination with uniformly hyperintense white matter on T<sub>2</sub>-weighted images; in less severely affected children, myelination is delayed and occurs especially in the periventricular regions [<xref ref-type="bibr" rid="pmd.REF.sonninen.1999.433">Sonninen et al 1999</xref>].</p>
          <p>PCWH, a syndrome with peripheral congenital hypomyelinating neuropathy, central dysmyelination, and Waardenburg-Hirschsprung disease, is caused by pathogenic truncating variants in <italic toggle="yes">SOX10</italic> [<xref ref-type="bibr" rid="pmd.REF.touraine.2000.1496">Touraine et al 2000</xref>, <xref ref-type="bibr" rid="pmd.REF.inoue.2002b.836">Inoue et al 2002b</xref>, <xref ref-type="bibr" rid="pmd.REF.inoue.2004.361">Inoue et al 2004</xref>].</p>
          <p>See also <related-object link-type="booklink" source-id="gene" document-id="leukodys-ov" document-type="chapter">Leukodystrophy Overview</related-object>.</p>
        </sec>
        <sec id="pmd.Spastic_Paraplegia_2_SPG2">
          <title>Spastic Paraplegia 2 (SPG2)</title>
          <p>Certain pathogenic variants in <italic toggle="yes">L1</italic> are responsible for <related-object link-type="booklink" source-id="gene" document-id="l1cam" document-type="chapter">L1 syndrome</related-object>, the phenotypic range of which includes X-linked spastic paraplegia type 1 (SPG1), MASA syndrome (intellectual disability, aphasia, shuffling gait, and adducted thumbs), and X-linked hydrocephalus. MRIs of individuals with these disorders may show enlarged ventricles or agenesis of the corpus callosum but not leukodystrophy.</p>
          <p>Pathogenic variants in <italic toggle="yes">GJC2</italic> (formerly called <italic toggle="yes">GJA12</italic>), encoding the connexin 47 protein, can cause a spastic paraplegia syndrome [<xref ref-type="bibr" rid="pmd.REF.orthmannmurphy.2009.426">Orthmann-Murphy et al 2009</xref>].</p>
          <p>Several other forms of autosomal dominant and autosomal recessive spastic paraplegia need to be considered in the differential diagnosis of SPG2; see <related-object link-type="booklink" source-id="gene" document-id="hsp" document-type="chapter">Hereditary Spastic Paraplegia Overview</related-object>.</p>
        </sec>
      </sec>
      <sec id="pmd.Management">
        <title>Management</title>
        <sec id="pmd.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual diagnosed with <italic toggle="yes">PLP1</italic>-related disorders, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Physical examination to determine extent and severity of respiratory and feeding difficulties, weakness, hypotonia, spasticity, scoliosis, ataxia, visual impairment, cognitive impairment, contractures, joint dislocations, and ambulation</p>
            </list-item>
            <list-item>
              <p>In infants and children, developmental assessment to determine capabilities and needs for cognitive, physical, and other symptomatic therapies</p>
            </list-item>
            <list-item>
              <p>Brain MRI (more helpful age &#x02265;9 months) to determine severity of myelination abnormalities; in older children and adults, magnetic resonance spectroscopy to ascertain axonal dysfunction</p>
            </list-item>
            <list-item>
              <p>Assessment of peripheral nerve function using NCV to presumptively identify individuals with the <italic toggle="yes">PLP1</italic> null syndrome; probably reliable only after age four years</p>
            </list-item>
            <list-item>
              <p>Family history to identify other affected or at-risk individuals</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="pmd.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>A multidisciplinary team comprising specialists in neurology, physical medicine, orthopedics, pulmonary medicine, and gastroenterology is optimal for care.</p>
          <p>Early attention to swallowing difficulties and airway protection, especially in the most severely affected individuals, is important. Those with severe dysphagia may require feeding by gastrostomy.</p>
          <p>Seizures are usually restricted to individuals with the most severe (connatal) syndrome and although they may not always be associated with electroencephalographic evidence for epileptiform waveforms, they generally respond to antiepileptic drugs (AEDs) such as carbamazepine.</p>
          <p>Spasticity management may include physical therapy and exercises, including regular stretching exercises. Antispasticity medications such as baclofen (including intrathecal administration), diazepam, and tizanidine may be helpful, especially in combination with physical therapy, exercise, orthotics, and other assistive devices. In advanced cases, surgery to release joint contractures may be required.</p>
          <p>Severe scoliosis may result in pulmonary compromise as well as discomfort, especially with position changes, and necessitate corrective surgery to preserve pulmonary function. Proper seating, especially wheelchair, and physical therapy may reduce or prevent the need for surgery.</p>
          <p>Specialized schooling arrangements are typically necessary for children with <italic toggle="yes">PLP1</italic>-related disorders. Developmental assessments can accurately assess a child's capabilities, which may be greater than is apparent because of severe motor deficits. Electronic or other communication devices may facilitate communication especially in children with visual and auditory impairment.</p>
        </sec>
        <sec id="pmd.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>Proper wheelchair seating and physical therapy may help prevent scoliosis. Speech and swallowing evaluations can help prevent or reduce aspiration and identify patients who may need a feeding tube for safer and/or adequate nutrition and hydration.</p>
        </sec>
        <sec id="pmd.Surveillance">
          <title>Surveillance</title>
          <p>Semiannual to annual neurologic and physical medicine evaluation is indicated to monitor developmental progress during childhood and to monitor and treat spasticity and orthopedic complications as needed.</p>
        </sec>
        <sec id="pmd.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>No specific agents or exposures are known to accelerate the long-term disease course.</p>
          <p>Elevated body temperature, as with fever, may cause neurologic signs and symptoms to transiently worsen, as occurs in individuals with multiple sclerosis (Uthoff phenomenon).</p>
        </sec>
        <sec id="pmd.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="pmd.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="pmd.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>CNS stem cells were recently transplanted into brains of individuals with PMD in a US FDA-approved Phase I trial [<xref ref-type="bibr" rid="pmd.REF.gupta.2012.155ra137">Gupta et al 2012</xref>]. The procedure was well tolerated and myelination was noted in the transplanted regions.</p>
          <p>Pharmacologic agents that lower expression of <italic toggle="yes">PLP1</italic> should be of theoretic benefit in individuals with extra copies of <italic toggle="yes">PLP1</italic>, and those with severe single-nucleotide variants. Preclinical studies are underway to test drugs of this type.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
        <sec id="pmd.Other">
          <title>Other</title>
          <p>No controlled studies, either successful or unsuccessful, have been reported for therapy of PMD or SPG2.</p>
        </sec>
      </sec>
      <sec id="pmd.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="pmd.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>The <italic toggle="yes">PLP1</italic>-related disorders are inherited in an X-linked manner.</p>
        </sec>
        <sec id="pmd.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a male proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The father of a proband will not have the disease nor will he be a carrier of the pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>Women who have an affected child and one other affected relative are obligate heterozygotes (carriers) and may manifest mild to moderate signs of the disease.</p>
            </list-item>
            <list-item>
              <p>If pedigree analysis reveals that the proband is the only affected family member, it is possible that his mother is a carrier or that he has a <italic toggle="yes">de novo PLP1</italic> single-nucleotide variant:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Most mothers of a proband are carriers of a <italic toggle="yes">PLP1</italic> pathogenic variant regardless of family history.</p>
                </list-item>
                <list-item>
                  <p><italic toggle="yes">De novo</italic> pathogenic variants have been reported for several <italic toggle="yes">PLP1</italic> single-nucleotide variants [<xref ref-type="bibr" rid="pmd.REF.hodes.1998.248">Hodes et al 1998</xref>] but not for <italic toggle="yes">PLP1</italic> duplications that appear to arise in the grandparental germline [<xref ref-type="bibr" rid="pmd.REF.woodward.1998b.207">Woodward et al 1998b</xref>, <xref ref-type="bibr" rid="pmd.REF.mimault.1999.360">Mimault et al 1999</xref>].</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a male proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs depends on the carrier status of the mother.</p>
            </list-item>
            <list-item>
              <p>Women with a <italic toggle="yes">PLP1</italic> pathogenic variant have a 50% chance of transmitting the variant to each child. Male sibs who inherit the variant will be affected; female sibs who inherit the variant will be carriers and may manifest mild to moderate signs of the disease. Of note, <italic toggle="yes">PLP1</italic> alleles that cause relatively mild neurologic signs in affected males are more likely to be associated with neurologic manifestations in heterozygotes.</p>
            </list-item>
            <list-item>
              <p>Germline mosaicism could occur in this condition. Thus, even if the pathogenic variant has not been identified in the mother's DNA, sibs of the proband are still at increased risk of inheriting the pathogenic variant [<xref ref-type="bibr" rid="pmd.REF.woodward.2003.15">Woodward et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p>Female sibs are more likely to develop neurologic signs if the phenotype in affected males is relatively mild (complicated or pure spastic paraparesis) [<xref ref-type="bibr" rid="pmd.REF.hurst.2006.371">Hurst et al 2006</xref>]. The risk to a heterozygous female of being clinically affected is highest when the brother has the <italic toggle="yes">PLP1</italic> null syndrome, and lowest when he has a <italic toggle="yes">PLP1</italic> duplication. Heterozygous females with <italic toggle="yes">PLP1</italic> duplication have been reported to have favorably skewed X inactivation [<xref ref-type="bibr" rid="pmd.REF.woodward.2000.449">Woodward et al 2000</xref>].</p>
            </list-item>
          </list>
          <p><bold>Offspring of a male proband.</bold> Males with typical PMD do not reproduce, but those with spastic paraplegia may be able to father children. Affected males transmit the <italic toggle="yes">PLP1</italic> pathogenic variant to all of their daughters and to none of their sons.</p>
          <p><bold>Other family members of a male proband.</bold> The proband's maternal aunts and their offspring may be at risk of being carriers or of being affected (depending on their gender, family relationship, and the carrier status of the proband's mother). Females who are heterozygous are more likely to have neurologic signs (usually adult-onset spastic paraparesis) if affected males have a less severe syndrome.</p>
        </sec>
        <sec id="pmd.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Heterozygotes are usually neurologically normal but may manifest mild-to-moderate signs of the disease.</p>
          <p>Carrier testing is possible if the <italic toggle="yes">PLP1</italic> pathogenic variant has been identified in the family.</p>
        </sec>
        <sec id="pmd.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Phenotypic variability.</bold> It is important for couples at risk to be aware that varying phenotypes can coexist in the same kindred or sibship; thus, families in which males have had a milder phenotype are at risk of having affected offspring who may display a more severe phenotype.</p>
          <p><bold>Distantly inserted duplications.</bold> While distantly inserted duplications are a rare cause of <italic toggle="yes">PLP1</italic>-related disorders, they may raise potentially difficult genetic counseling issues because the inheritance pattern may not be X linked [<xref ref-type="bibr" rid="pmd.REF.hodes.2000.14">Hodes et al 2000</xref>, <xref ref-type="bibr" rid="pmd.REF.inoue.2002a.838">Inoue et al 2002a</xref>].</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="pmd.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>Prenatal testing is possible for pregnancies of women who are carriers if the <italic toggle="yes">PLP1</italic> pathogenic variant has been identified in the family [<xref ref-type="bibr" rid="pmd.REF.woodward.1999.266">Woodward et al 1999</xref>, <xref ref-type="bibr" rid="pmd.REF.regis.2001.668">Regis et al 2001</xref>]. The usual procedure is to determine fetal sex by DNA analysis or cytogenetic analysis of fetal cells obtained by amniocentesis (usually performed at ~15-18 weeks&#x02019; gestation) or chorionic villus sampling (usually performed at ~10-12 weeks&#x02019; gestation). If the fetus is male, DNA from fetal cells can be analyzed for the known pathogenic variant. The phenotype of an affected fetus cannot be accurately predicted as widely varying phenotypes often coexist in the same kindred or sibship; thus, families in which males have had a milder phenotype are at risk of having affected offspring with a more severe phenotype. In addition, females who inherit the pathogenic variant will be carriers and may manifest mild to moderate signs of the disease.</p>
          <p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the pathogenic variant has been identified.</p>
          <p>PGD has been used successfully not only for gender selection [<xref ref-type="bibr" rid="pmd.REF.de_diesmulders.1998.2441">de Die-Smulders et al 1998</xref>] but also to select against pathogenic <italic toggle="yes">PLP1</italic> single-nucleotide variants [<xref ref-type="bibr" rid="pmd.REF.verlinsky.2006.83">Verlinsky et al 2006</xref>]. PGD has not yet been reported in families that have <italic toggle="yes">PLP1</italic> copy number variants, but it should be possible to use linked markers, unique junction fragments, and/or oligonucleotide arrays to detect <italic toggle="yes">PLP1</italic> copy number variants.</p>
        </sec>
      </sec>
      <sec id="pmd.Resources">
        <title>Resources</title>
      </sec>
      <sec id="pmd.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="pmd.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>For a review of molecular pathophysiology and genetics of Pelizaeus-Merzbacher disease (PMD), see <xref ref-type="bibr" rid="pmd.REF.garbern.2007.50">Garbern [2007]</xref>, <xref ref-type="bibr" rid="pmd.REF.woodward.2008.e14">Woodward [2008]</xref>, and <xref ref-type="bibr" rid="pmd.REF.hobson.2012.62">Hobson &#x00026; Garbern [2012]</xref></p>
          <p><xref ref-type="bibr" rid="pmd.REF.yool.2000.987">Yool et al [2000]</xref> reviewed features of <italic toggle="yes">PLP1</italic> pathogenic variants both in humans and in animal models. The clinical syndromes caused by small intragenic pathogenic variants are quite broad, ranging from mild spastic paraparesis and ataxia to severe spastic quadriplegia, seizures, stridor, and childhood fatality. A compelling hypothesis to explain the variation in clinical severities of different <italic toggle="yes">PLP1</italic> pathogenic variants has been put forward by <xref ref-type="bibr" rid="pmd.REF.gow.1996.422">Gow &#x00026; Lazzarini [1996]</xref> and <xref ref-type="bibr" rid="pmd.REF.southwood.2001.700">Southwood &#x00026; Gow [2001]</xref>. Pathogenic missense variants and other small intragenic variants presumably cause misfolding of myelin proteolipid protein (PLP1) or the PLP1 isoform DM20. These misfolded proteins fail to progress through the intracellular processing pathway and are retained in the endoplasmic reticulum (ER), failing to be incorporated into the cell membrane and to activate the unfolded protein response (UPR) [<xref ref-type="bibr" rid="pmd.REF.southwood.2002.585">Southwood et al 2002</xref>]. As oligodendrocytes attempt to myelinate their axons, UPR-activated apoptosis ensues if both PLP1 and DM20 are retained in the ER. However, if only PLP1 but not DM20 is ER-retained, oligodendrocytes survive and myelinate, resulting in a less severe syndrome such as spastic paraplegia.</p>
          <p>Overexpression of PLP1 is presumed to be the mechanism triggered by increased <italic toggle="yes">PLP1</italic> dosage. Experimental studies suggest that increased PLP1 expression results in mislocalization of PLP1 along with cholesterol and lipids to the late endosomal/lysosomal compartment [<xref ref-type="bibr" rid="pmd.REF.simons.2000.143">Simons et al 2000</xref>]. In addition, increased gene dosage of PLP1 is associated with increased CSF levels of N-aspartylglutamate (NAAG) [<xref ref-type="bibr" rid="pmd.REF.mochel.2010.1112">Mochel et al 2010</xref>], suggesting that there is a diffuse axonal injury in PMD. The association of dysmyelination and axonal injury in PMD and other leukodystrophies is reviewed by <xref ref-type="bibr" rid="pmd.REF.mar.2010.239">Mar &#x00026; Noetzel [2010]</xref>.</p>
          <p>Deletion of <italic toggle="yes">PLP1</italic>, and probably some splice-site variants that preclude expression of PLP1, result in mild myelin defects but more severe axonal degeneration [<xref ref-type="bibr" rid="pmd.REF.garbern.2002.551">Garbern et al 2002</xref>].</p>
          <p>Some intrafamilial phenotypic variability can occur, presumably the result of genetic background or environmental effects that are not understood. An interesting animal model highlights the effect of genetic background. In the C3H mouse strain, the p.Ile187Thr missense ("rumpshaker") variant causes a mild syndrome with normal life span (~2 years) but causes a fatal syndrome in the C57BL/6 strain background [<xref ref-type="bibr" rid="pmd.REF.alsaktawi.2003.12">Al-Saktawi et al 2003</xref>].</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">PLP1</italic> comprises seven exons spanning approximately 15 kbp. <italic toggle="yes">PLP1</italic> encodes two major alternatively spliced transcripts: a full-length transcript encodes myelin proteolipid protein (PLP1) and the transcript variant DM20, which lacks the <italic toggle="yes">PLP1</italic>-specific domain encoded by residues 117-151. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="pmd" object-id="pmd.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Benign allelic variants.</bold> Selected benign (non-disease-causing) allelic variants reported in <italic toggle="yes">PLP1</italic> are listed <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="pmd-suppdata.pdf" content-type="local-data">here</inline-supplementary-material>.</p>
          <p><bold>Normal gene product.</bold> Myelin proteolipid protein 1 (PLP1) is the predominant protein constituent of central nervous system myelin, constituting approximately 50% of the myelin protein mass. Among mammals, PLP1 is highly conserved, with the mouse, rat, and human PLP1 sequences being completely identical over the 276-amino acid sequence. Other mammalian PLP1s differ at only a handful of residues. In addition to myelin proteolipid protein, at least one additional gene product, the isoform DM20, is encoded by <italic toggle="yes">PLP1</italic>. PLP1 and DM20 are both predicted to be transmembrane proteins that span the lipid bilayer four times. In addition, protein is anchored further to cell membranes through covalent acyl linkages to fatty acids. It is thought that PLP1 probably cements adjacent leaflets of myelin; however, additional or alternative functions are also possible [<xref ref-type="bibr" rid="pmd.REF.griffiths.1998.344">Griffiths et al 1998</xref>].</p>
          <p>A product of alternative splicing, the DM20 isoform is also found in the peripheral nervous system and other tissues. The splicing variation occurs at exon 3, where the 3' half of the exon is spliced out in DM20 mRNA, resulting in the in-frame deletion of amino acid residues 117-151.</p>
          <p>Post-translational proteolytic cleavage of PLP1/DM20 appears to occur in vivo [<xref ref-type="bibr" rid="pmd.REF.bizzozero.2002.636">Bizzozero et al 2002</xref>]. There is evidence that PLP1-derived peptides promote oligodendrocyte mitogenesis [<xref ref-type="bibr" rid="pmd.REF.yamada.1999.2143">Yamada et al 1999</xref>]. In addition, PLP1, but not DM20, has also recently been shown to form dimers at an intracellular cysteine residue [<xref ref-type="bibr" rid="pmd.REF.daffu.2012.144">Daffu et al 2012</xref>]. This dimerization may contribute to the molecular pathogenesis of PMD, both in patients with indels and those with duplications.</p>
          <p><bold>Abnormal gene product.</bold> Duplication of <italic toggle="yes">PLP1</italic> presumably results in overexpression of myelin proteolipid protein (PLP1), leading to dysfunction and death of oligodendrocytes, the myelin-forming cells in the CNS. Transgenic mice that overexpress normal myelin proteolipid protein develop both dysmelination and demyelination of the CNS [<xref ref-type="bibr" rid="pmd.REF.griffiths.1998.344">Griffiths et al 1998</xref>, <xref ref-type="bibr" rid="pmd.REF.yool.2000.987">Yool et al 2000</xref>].</p>
        </sec>
      </sec>
      <sec id="pmd.References">
        <title>References</title>
        <sec id="pmd.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="pmd.Literature_Cited.reflist0">
            <ref id="pmd.REF.alsaktawi.2003.12">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al-Saktawi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLaughlin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klugmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrie</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCulloch</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montague</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirkham</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nave</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffiths</surname>
                    <given-names>IR</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Genetic background determines phenotypic severity of the Plp rumpshaker mutation.</article-title>
                <source>J Neurosci Res</source>
                <volume>72</volume>
                <fpage>12</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">12645075</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.barkovich.2005.311">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barkovich</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Magnetic resonance techniques in the assessment of myelin and myelination.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>28</volume>
                <fpage>311</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">15868466</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.biancheri.2007.121">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Biancheri</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruno</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bordo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gazzerro</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sotgia</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedemonte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scapolan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bado</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uziel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bugiani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamba</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costa</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schenone</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rozemuller</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tortori-Donati</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lisanti</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minetti</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Phenotypic characterization of hypomyelination and congenital cataract.</article-title>
                <source>Ann Neurol</source>
                <volume>62</volume>
                <fpage>121</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17683097</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.bizzozero.2002.636">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bizzozero</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malkoski</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mobarak</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bixler</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Mass-spectrometric analysis of myelin proteolipids reveals new features of this family of palmitoylated membrane proteins.</article-title>
                <source>J Neurochem</source>
                <volume>81</volume>
                <fpage>636</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">12065672</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.boespflugtanguy.1994.461">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mimault</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melki</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavagna</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giraud</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pham Dinh</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dastugue</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dautigny</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Genetic homogeneity of Pelizaeus-Merzbacher disease: tight linkage to the proteolipoprotein locus in 16 affected families. PMD Clinical Group.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>55</volume>
                <fpage>461</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">7915877</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.bonavita.2001.785">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bonavita</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frei</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patronas</surname>
                    <given-names>MD N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Virta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tedeschi</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Evidence for neuroaxonal injury in patients with proteolipid protein gene mutations.</article-title>
                <source>Neurology</source>
                <volume>56</volume>
                <fpage>785</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11274318</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.bonkowsky.2010.718">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bonkowsky</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kingston</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filloux</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mundorff</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Srivastava</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>The burden of inherited leukodystrophies in children.</article-title>
                <source>Neurology</source>
                <volume>75</volume>
                <fpage>718</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">20660364</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.boulloche.1986.233">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boulloche</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aicardi</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1986</year>
                <article-title>Pelizaeus-Merzbacher disease: clinical and nosological study.</article-title>
                <source>J Child Neurol</source>
                <volume>1</volume>
                <fpage>233</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">3598129</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.bugiani.2006.273">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bugiani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Shahwan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamantea</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bizzi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakhsh</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moroni</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balestrini</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uziel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy.</article-title>
                <source>Neurology.</source>
                <volume>67</volume>
                <fpage>273</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16707726</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.cailloux.2000.837">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cailloux</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gauthier-Barichard</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mimault</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isabelle</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Courtois</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giraud</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dastugue</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Clinical European Network on Brain Dysmyelinating Disease.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>8</volume>
                <fpage>837</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">11093273</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.combes.2006.31">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Combes</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnet-Dupeyron</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gauthier-Barichard</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armour</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaurs-Barri&#x000e8;re</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>PLP1 and GPM6B intragenic copy number analysis by MAPH in 262 patients with hypomyelinating leukodystrophies: identification of one partial triplication and two partial deletions of PLP1.</article-title>
                <source>Neurogenetics</source>
                <volume>7</volume>
                <fpage>31</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16416265</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.daffu.2012.144">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Daffu</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sohi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamholz</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Proteolipid protein dimerization at cysteine 108: Implications for protein structure.</article-title>
                <source>Neurosci Res</source>
                <volume>74</volume>
                <fpage>144</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">22902553</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.de_diesmulders.1998.2441">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Die-Smulders</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geraedts</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dreesen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coonen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Land</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Genetic diagnosis of IVF embryos: preliminary results from 'preimplantation genetic diagnoses' in the Netherlands.</article-title>
                <source>Ned Tijdschr Geneeskd</source>
                <volume>142</volume>
                <fpage>2441</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">10028321</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.gao.2005.466">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gao</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thurston</surname>
                    <given-names>VC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vance</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dlouhy</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodes</surname>
                    <given-names>ME</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Genetic diagnosis of PLP gene duplications/deletions in patients with Pelizaeus-Merzbacher disease.</article-title>
                <source>Clin Genet</source>
                <volume>68</volume>
                <fpage>466</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16207216</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.garbern.2002.1033">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Garbern</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hobson</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Prenatal diagnosis of Pelizaeus-Merzbacher disease.</article-title>
                <source>Prenat Diagn</source>
                <volume>22</volume>
                <fpage>1033</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12424770</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.garbern.2007.50">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Garbern</surname>
                    <given-names>JY</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Pelizaeus-Merzbacher disease: genetic and cellular pathogenesis.</article-title>
                <source>Cell Mol Life Sci</source>
                <volume>64</volume>
                <fpage>50</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">17115121</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.garbern.2002.551">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Garbern</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yool</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilds</surname>
                    <given-names>IB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faulk</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klugmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nave</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sistermans</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shy</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamholz</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffiths</surname>
                    <given-names>IR</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation.</article-title>
                <source>Brain</source>
                <volume>125</volume>
                <fpage>551</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">11872612</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.gow.1996.422">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gow</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lazzarini</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease.</article-title>
                <source>Nat Genet</source>
                <volume>13</volume>
                <fpage>422</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8696336</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.griffiths.1998.344">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Griffiths</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klugmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vouyiouklis</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nave</surname>
                    <given-names>KA</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Current concepts of PLP and its role in the nervous system.</article-title>
                <source>Microsc Res Tech</source>
                <volume>41</volume>
                <fpage>344</fpage>
                <lpage>58</lpage>
                <pub-id pub-id-type="pmid">9672418</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.gupta.2012.155ra137">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henry</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strober</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bucci</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caverzasi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaetano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandelli</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryan</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perry</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrell</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeremy</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ulman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huhn</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barkovich</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rowitch</surname>
                    <given-names>DH</given-names>
                  </name>
                </person-group>
                <article-title>Neural stem cell engraftment and myelination in the human brain.</article-title>
                <source>Sci Transl Med.</source>
                <year>2012</year>
                <volume>4</volume>
                <fpage>155ra137</fpage>
                <pub-id pub-id-type="pmid">23052294</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.hanefeld.2005.701">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hanefeld</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pouwels</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilken</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frahm</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dechent</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination.</article-title>
                <source>Neurology</source>
                <volume>65</volume>
                <fpage>701</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16157902</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.heim.1997.475">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heim</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claussen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conzelmann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gartner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harzer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunneman</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohler</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurlemann</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlschutter</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Leukodystrophy incidence in Germany.</article-title>
                <source>Am J Med Genet</source>
                <volume>71</volume>
                <fpage>475</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9286459</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.henneke.2008.748">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Henneke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Combes</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diekmann</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlina</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaiser</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohlenbusch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plecko</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000e4;rtner</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease.</article-title>
                <source>Neurology.</source>
                <volume>70</volume>
                <fpage>748</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">18094336</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.hobson.2000.1089">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hobson</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stowell</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolodny</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sistermans</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Coo</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Funanage</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marks</surname>
                    <given-names>HG</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Mutations in noncoding regions of the proteolipid protein gene in Pelizaeus-Merzbacher disease.</article-title>
                <source>Neurology</source>
                <volume>55</volume>
                <fpage>1089</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">11071483</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.hobson.2012.62">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hobson</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garbern</surname>
                    <given-names>JY</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease 1, and related hypomyelinating disorders.</article-title>
                <source>Semin Neurol</source>
                <volume>32</volume>
                <fpage>62</fpage>
                <lpage>67</lpage>
                <pub-id pub-id-type="pmid">22422208</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.hobson.2006.69">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hobson</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperle</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sistermans</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogan</surname>
                    <given-names>PK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garbern</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolodny</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naidu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cambi</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Splice-site contribution in alternative splicing of PLP1 and DM20: molecular studies in oligodendrocytes.</article-title>
                <source>Hum Mutat</source>
                <volume>27</volume>
                <fpage>69</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">16287154</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.hobson.2002a.477">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hobson</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperle</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stabley</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marks</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cambi</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2002a</year>
                <article-title>A PLP splicing abnormality is associated with an unusual presentation of PMD.</article-title>
                <source>Ann Neurol</source>
                <volume>52</volume>
                <fpage>477</fpage>
                <lpage>88</lpage>
                <pub-id pub-id-type="pmid">12325077</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.hobson.2002b.2045a">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hobson</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ritterson</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raskind</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garbern</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperle</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2002b</year>
                <article-title>Deletion breakpoint analysis in a patient with Pelizaeus-Merzbacher disease (PMD) and comparison with duplications.</article-title>
                <source>Am J Hum Genet</source>
                <volume>71</volume>
                <fpage>2045A</fpage>
              </element-citation>
            </ref>
            <ref id="pmd.REF.hodes.1998.248">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hodes</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aydanian</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dlouhy</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whelan</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heshka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ronen</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>A de novo mutation (C755T; Ser252Phe) in exon 6 of the proteolipid protein gene responsible for Pelizaeus-Merzbacher disease</article-title>
                <comment>[letter]</comment>
                <source>Clin Genet</source>
                <volume>54</volume>
                <fpage>248</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9788732</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.hodes.1993.383">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hodes</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pratt</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dlouhy</surname>
                    <given-names>SR</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Genetics of Pelizaeus-Merzbacher disease.</article-title>
                <source>Dev Neurosci</source>
                <volume>15</volume>
                <fpage>383</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">7530633</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.hodes.2000.14">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hodes</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodward</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emanuel</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enrico-Simon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamholz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stambolian</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zackai</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pratt</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>IT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crandall</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dlouhy</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malcolm</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Additional copies of the proteolipid protein gene causing Pelizaeus-Merzbacher disease arise by separate integration into the X chromosome.</article-title>
                <source>Am J Hum Genet</source>
                <volume>67</volume>
                <fpage>14</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">10827108</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.hodes.1999.132">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hodes</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimmerman</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aydanian</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naidu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia Oller</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barker</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aleck</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hurley</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dlouhy</surname>
                    <given-names>SR</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Different mutations in the same codon of the proteolipid protein gene, PLP, may help in correlating genotype with phenotype in Pelizaeus- Merzbacher disease/X-linked spastic paraplegia (PMD/SPG2).</article-title>
                <source>Am J Med Genet</source>
                <volume>82</volume>
                <fpage>132</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9934976</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.h_bner.2005.321">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>H&#x000fc;bner</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orth</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senning</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steglich</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlschutter</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korinthenberg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gal</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Seventeen novel PLP1 mutations in patients with Pelizaeus-Merzbacher disease.</article-title>
                <source>Hum Mutat</source>
                <volume>25</volume>
                <fpage>321</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">15712223</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.hurst.2006.371">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hurst</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garbern</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trepanier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gow</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Quantifying the carrier female phenotype in Pelizaeus-Merzbacher disease.</article-title>
                <source>Genet Med</source>
                <volume>8</volume>
                <fpage>371</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16778599</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.inoue.2004.361">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khajavi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohyama</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirabayashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reggin</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancias</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butler</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilkinson</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wegner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations.</article-title>
                <source>Nat Genet</source>
                <volume>36</volume>
                <fpage>361</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15004559</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.inoue.1999.624">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imaizumi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nezu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takanashi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arii</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murayama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ono</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kikawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mito</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaffer</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Proteolipid protein gene duplications causing Pelizaeus-Merzbacher disease: molecular mechanism and phenotypic manifestations.</article-title>
                <source>Ann Neurol</source>
                <volume>45</volume>
                <fpage>624</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">10319885</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.inoue.2002a.838">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thurston</surname>
                    <given-names>VC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clarke</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoneyama</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenbarker</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodes</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaffer</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2002a</year>
                <article-title>Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females.</article-title>
                <source>Am J Hum Genet</source>
                <volume>71</volume>
                <fpage>838</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">12297985</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.inoue.2002b.836">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shilo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boerkoel</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crowe</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sawady</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agamanolis</surname>
                    <given-names>DP</given-names>
                  </name>
                </person-group>
                <year>2002b</year>
                <article-title>Congenital hypomyelinating neuropathy, central dysmyelination, and Waardenburg-Hirschsprung disease: phenotypes linked by SOX10 mutation.</article-title>
                <source>Ann Neurol</source>
                <volume>52</volume>
                <fpage>836</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">12447940</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.inoue.2001.747">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scaglia</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Araki</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaffer</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Compensating for central nervous system dysmyelination: females with a proteolipid protein gene duplication and sustained clinical improvement.</article-title>
                <source>Ann Neurol</source>
                <volume>50</volume>
                <fpage>747</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">11761472</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.johnson.2002.391">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>AB</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Alexander disease: a review and the gene.</article-title>
                <source>Int J Dev Neurosci.</source>
                <volume>20</volume>
                <fpage>391</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">12175878</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.lee.2006.398">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madrid</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperle</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ritterson</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hobson</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garbern</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Spastic paraplegia type 2 associated with axonal neuropathy and apparent PLP1 position effect.</article-title>
                <source>Ann Neurol</source>
                <volume>59</volume>
                <fpage>398</fpage>
                <lpage>403</lpage>
                <pub-id pub-id-type="pmid">16374829</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.lee.2007.1235">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carvalho</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders.</article-title>
                <source>Cell</source>
                <volume>131</volume>
                <fpage>1235</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">18160035</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.leegwater.2001.383">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leegwater</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeulen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konst</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naidu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulders</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Visser</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kersbergen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mobach</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fonds</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Berkel</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lemmers</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oudejans</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schutgens</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pronk</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter.</article-title>
                <source>Nat Genet</source>
                <volume>29</volume>
                <fpage>383</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11704758</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.magen.2008.30">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Magen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Georgopoulos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bross</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Segev</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldsher</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nemirovski</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shahar</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravid</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luder</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heno</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gershoni-Baruch</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skorecki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy.</article-title>
                <source>Am J Hum Genet</source>
                <volume>83</volume>
                <fpage>30</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">18571143</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.mar.2010.239">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mar</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noetzel</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Axonal damage in leukodystrophies.</article-title>
                <source>Pediatr Neurol</source>
                <volume>42</volume>
                <fpage>239</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">20304325</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.mercuri.1995.3">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mercuri</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berardinelli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pennock</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philpot</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubowitz</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Somatosensory and visual evoked potentials in congenital muscular dystrophy: correlation with MRI changes and muscle merosin status.</article-title>
                <source>Neuropediatrics</source>
                <volume>26</volume>
                <fpage>3</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">7791947</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.merzbacher.1910.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Merzbacher</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>1910</year>
                <article-title>Eine eigenarige familiar-hereditare Erkrankungsform (Aplasia axialis extra-corticalis congenita).</article-title>
                <source>Z Neurol Psychiatr.</source>
                <volume>3</volume>
                <fpage>1</fpage>
                <lpage>138</lpage>
              </element-citation>
            </ref>
            <ref id="pmd.REF.mimault.1999.360">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mimault</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giraud</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Courtois</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cailloux</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boire</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dastugue</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus- Merzbacher Disease: duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not. The Clinical European Network on Brain Dysmyelinating Disease.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>65</volume>
                <fpage>360</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10417279</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.mochel.2010.1112">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mochel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boildieu</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barritault</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarret</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard-Pierre</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seguin</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Elevated CSF N-acetylaspartylglutamate suggests specific molecular diagnostic abnormalities in patients with white matter diseases.</article-title>
                <source>Biochem Biophys Acta</source>
                <volume>1802</volume>
                <fpage>1112</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">20637281</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.muncke.2004.e121">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Muncke</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wogatzky</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breuning</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sistermans</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Endris</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vetrie</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Catsman-Berrevoets</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rappold</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Position effect on PLP1 may cause a subset of Pelizaeus-Merzbacher disease symptoms.</article-title>
                <source>J Med Genet</source>
                <volume>41</volume>
                <fpage>e121</fpage>
                <pub-id pub-id-type="pmid">15591263</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.nezu.1998.334">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nezu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimura</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takeshita</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>An MRI and MRS study of Pelizaeus-Merzbacher disease.</article-title>
                <source>Pediatr Neurol</source>
                <volume>18</volume>
                <fpage>334</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9588530</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.orthmannmurphy.2007.629">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Orthmann-Murphy</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enriquez</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abrams</surname>
                    <given-names>CK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scherer</surname>
                    <given-names>SS</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Loss-of-function GJA12/Connexin47 mutations cause Pelizaeus-Merzbacher-like disease.</article-title>
                <source>Mol Cell Neurosci.</source>
                <volume>34</volume>
                <fpage>629</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">17344063</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.orthmannmurphy.2009.426">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Orthmann-Murphy</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salsano</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abrams</surname>
                    <given-names>CK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bizzi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uziel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freidin</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamantea</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scherer</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pareyson</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations.</article-title>
                <source>Brain.</source>
                <volume>132</volume>
                <fpage>426</fpage>
                <lpage>38</lpage>
                <pub-id pub-id-type="pmid">19056803</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.padiath.2006.1114">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Padiath</surname>
                    <given-names>QS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saigoh</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asahara</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koeppen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hogan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pt&#x000e1;cek</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fu</surname>
                    <given-names>YH</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Lamin B1 duplications cause autosomal dominant leukodystrophy.</article-title>
                <source>Nat Genet</source>
                <volume>38</volume>
                <fpage>1114</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">16951681</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.pelizaeus.1885.698">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pelizaeus</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>1885</year>
                <article-title>Uber eine eigenthuiche Form spastischer Lahmung mit Cerebralerschinungen auf hereditarer Grundlage (Multiple Sklerose).</article-title>
                <source>Arch Psychiatr Nervenkr</source>
                <volume>16</volume>
                <fpage>698</fpage>
                <lpage>710</lpage>
              </element-citation>
            </ref>
            <ref id="pmd.REF.plecko.2003.127">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Plecko</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stockler-Ipsiroglu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gruber</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mlynarik</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moser</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simbrunner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebner</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernert</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harrer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gal</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prayer</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Degree of hypomyelination and magnetic resonance spectroscopy findings in patients with Pelizaeus Merzbacher phenotype.</article-title>
                <source>Neuropediatrics</source>
                <volume>34</volume>
                <fpage>127</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">12910435</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.pronk.2006.123">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pronk</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Kollenburg</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Vanishing white matter disease: a review with focus on its genetics.</article-title>
                <source>Ment Retard Dev Disabil Res Rev.</source>
                <volume>12</volume>
                <fpage>123</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16807905</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.raskind.1991.1355">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Raskind</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hudson</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Complete deletion of the proteolipid protein gene (PLP) in a family with X-linked Pelizaeus-Merzbacher disease.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>49</volume>
                <fpage>1355</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">1720927</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.regis.2001.668">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Regis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filocamo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazzotti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cusano</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corsolini</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonuccelli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stroppiano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gatti</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Prenatal diagnosis of Pelizaeus-Merzbacher disease: detection of proteolipid protein gene duplication by quantitative fluorescent multiplex PCR.</article-title>
                <source>Prenat Diagn</source>
                <volume>21</volume>
                <fpage>668</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">11536268</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.regis.2005.73">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Regis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grossi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lualdi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biancheri</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filocamo</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Diagnosis of Pelizaeus-Merzbacher disease: detection of proteolipid protein gene copy number by real-time PCR.</article-title>
                <source>Neurogenetics</source>
                <volume>6</volume>
                <fpage>73</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15827763</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.ruf.2009.226">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ruf</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uhlenberg</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Analysis of human alternative first exons and copy number variation of the GJA12 gene in patients with Pelizaeus-Merzbacher-like disease.</article-title>
                <source>Am J Med Genet B Neuropsychiatr Genet.</source>
                <volume>150B</volume>
                <fpage>226</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">18521858</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.salviati.2007.57">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Salviati</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trevisson</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baldoin</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toldo</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sartori</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calderone</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tenconi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laverda</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A novel deletion in the GJA12 gene causes Pelizaeus-Merzbacher-like disease.</article-title>
                <source>Neurogenetics.</source>
                <volume>8</volume>
                <fpage>57</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">17031678</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.sartori.2008.348">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sartori</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlina</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salviati</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trevisson</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toldo</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laverda</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlina</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Increased level of N-acetylaspartylglutamate (NAAG) in the CSF of a patient with Pelizaeus-Merzbacher-like disease due to mutation in the GJA12 gene.</article-title>
                <source>Eur J Paediatr Neurol.</source>
                <volume>12</volume>
                <fpage>348</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">17881259</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.scali.2006.271">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scali</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Perri</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>The spectrum of mutations for the diagnosis of vanishing white matter disease.</article-title>
                <source>Neurol Sci.</source>
                <volume>27</volume>
                <fpage>271</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16998732</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.seeman.2003.95">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Seeman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krsck</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Namestkova</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malikova</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belsan</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Proskova</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Pelizaeus-Merzbacher's Disease (PMD) - Detection of the most frequent mutation of the Proteolipid protein gene in Czech patients and famillies with the classical form of PMD.</article-title>
                <source>Ceska Slovenska Neurol Neurochir</source>
                <volume>66</volume>
                <fpage>95</fpage>
                <lpage>104</lpage>
              </element-citation>
            </ref>
            <ref id="pmd.REF.shy.2003.354">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shy</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hobson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jain</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garbern</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperle</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gow</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancias</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krajewski</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamholz</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy.</article-title>
                <source>Ann Neurol</source>
                <volume>53</volume>
                <fpage>354</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">12601703</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.simons.2000.143">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Simons</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kramer</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiele</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoffel</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trotter</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Assembly of myelin by association of proteolipid protein with cholesterol- and galactosylceramide-rich membrane domains.</article-title>
                <source>J Cell Biol</source>
                <volume>151</volume>
                <fpage>143</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">11018060</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.sistermans.1998.1749">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sistermans</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Coo</surname>
                    <given-names>RF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Wijs</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Oost</surname>
                    <given-names>BA</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Duplication of the proteolipid protein gene is the major cause of Pelizaeus-Merzbacher disease.</article-title>
                <source>Neurology</source>
                <volume>50</volume>
                <fpage>1749</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">9633722</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.sivakumar.1999.680">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sivakumar</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sambuughin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selenge</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagle</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baasanjav</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hudson</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldfarb</surname>
                    <given-names>LG</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Novel exon 3B proteolipid protein gene mutation causing late-onset spastic paraplegia type 2 with variable penetrance in female family members.</article-title>
                <source>Ann Neurol</source>
                <volume>45</volume>
                <fpage>680</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">10319897</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.sonninen.1999.433">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sonninen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Autti</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varho</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamalainen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raininko</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Brain involvement in Salla disease.</article-title>
                <source>AJNR Am J Neuroradiol</source>
                <volume>20</volume>
                <fpage>433</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">10219409</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.southwood.2001.700">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Southwood</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gow</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Molecular pathways of oligodendrocyte apoptosis revealed by mutations in the proteolipid protein gene.</article-title>
                <source>Microsc Res Tech</source>
                <volume>52</volume>
                <fpage>700</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11276122</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.southwood.2002.585">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Southwood</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garbern</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gow</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease.</article-title>
                <source>Neuron</source>
                <volume>36</volume>
                <fpage>585</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">12441049</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.takanashi.2002.237">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Takanashi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurihara</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morita</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikehira</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanada</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshitome</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohno</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Brain N-acetylaspartate is elevated in Pelizaeus-Merzbacher disease with PLP1 duplication.</article-title>
                <source>Neurology</source>
                <volume>58</volume>
                <fpage>237</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">11805250</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.touraine.2000.1496">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Touraine</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attie-Bitach</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manceau</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korsch</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarda</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pingault</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Encha-Razavi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelet</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auge</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nivelon-Chevallier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holschneider</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnes</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doerfler</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goossens</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vekemans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyonnet</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Neurological phenotype in Waardenburg syndrome type 4 correlates with novel SOX10 truncating mutations and expression in developing brain.</article-title>
                <source>Am J Hum Genet</source>
                <volume>66</volume>
                <fpage>1496</fpage>
                <lpage>503</lpage>
                <pub-id pub-id-type="pmid">10762540</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.uhlenberg.2004.251">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Uhlenberg</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schuelke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruschendorf</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruf</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaindl</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henneke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiele</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoltenburg-Didinger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aksu</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topaloglu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nurnberg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hubner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weschke</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gartner</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutations in the Gene Encoding Gap Junction Protein alpha 12 (Connexin 46.6) Cause Pelizaeus-Merzbacher-Like Disease.</article-title>
                <source>Am J Hum Genet</source>
                <volume>75</volume>
                <fpage>251</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">15192806</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.van_der_knaap.2001.541">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naidu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breiter</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blaser</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stroink</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Springer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Begeer</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Coster</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barth</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>NH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valk</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powers</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Alexander disease: diagnosis with MR imaging.</article-title>
                <source>AJNR Am J Neuroradiol</source>
                <volume>22</volume>
                <fpage>541</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">11237983</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.van_der_knaap.2006.413">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pronk</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Vanishing white matter disease.</article-title>
                <source>Lancet Neurol.</source>
                <volume>5</volume>
                <fpage>413</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">16632312</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.vaursbarri_re.2003.769">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vaurs-Barri&#x000e8;re</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weibel</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abu-Asab</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiss</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneski</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mixon</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonavita</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Creveaux</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heiss</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsokos</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quarles</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Insertion of mutant proteolipid protein results in missorting of myelin proteins.</article-title>
                <source>Ann Neurol</source>
                <volume>54</volume>
                <fpage>769</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">14681886</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.vaursbarri_re.2009.114">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vaurs-Barri&#x000e8;re</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deville</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarret</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giraud</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Des Portes</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prats-Vi&#x000f1;as</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Michele</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dan</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brady</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Touraine</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects.</article-title>
                <source>Ann Neurol</source>
                <volume>65</volume>
                <fpage>114</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19194886</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.verlinsky.2006.83">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verlinsky</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rechitsky</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laziuk</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Librach</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genovese</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuliev</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Preimplantation genetic diagnosis for Pelizaeus-Merzbacher disease with testing for age-related aneuploidies.</article-title>
                <source>Reprod Biomed Online</source>
                <volume>12</volume>
                <fpage>83</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16454941</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.wang.2006.999">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hobson</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dimova</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperle</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCullough</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cambi</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>PLP1 alternative splicing in differentiating oligodendrocytes: characterization of an exonic splicing enhancer.</article-title>
                <source>J Cell Biochem</source>
                <volume>97</volume>
                <fpage>999</fpage>
                <lpage>1016</lpage>
                <pub-id pub-id-type="pmid">16288477</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.warshawsky.2006.1267">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Warshawsky</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chernova</surname>
                    <given-names>OB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hubner</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stindl</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henneke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gal</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Natowicz</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Multiplex ligation-dependent probe amplification for rapid detection of proteolipid protein 1 gene duplications and deletions in affected males and carrier females with Pelizaeus-Merzbacher disease.</article-title>
                <source>Clin Chem</source>
                <volume>52</volume>
                <fpage>1267</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">16644873</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.wolf.2005.743">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>NI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sistermans</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cundall</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hobson</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis-Williams</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stubbs</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Endziniene</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chong</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malcolm</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Surtees</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garbern</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodward</surname>
                    <given-names>KJ</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Three or more copies of the proteolipid protein gene PLP1 cause severe Pelizaeus-Merzbacher disease.</article-title>
                <source>Brain</source>
                <volume>128</volume>
                <fpage>743</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">15689360</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.wolf.2007.39">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>NI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cundall</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rutland</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosser</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Surtees</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benton</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chong</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malcolm</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebinger</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bitner-Glindzicz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodward</surname>
                    <given-names>KJ</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Frameshift mutation in GJA12 leading to nystagmus, spastic ataxia and CNS dys-/demyelination.</article-title>
                <source>Neurogenetics.</source>
                <volume>8</volume>
                <fpage>39</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">16969684</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.woodward.2008.e14">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Woodward</surname>
                    <given-names>KJ</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>The molecular and cellular defects underlying Pelizaeus-Merzbacher disease.</article-title>
                <source>Expert Rev Mol Med</source>
                <volume>10</volume>
                <fpage>e14</fpage>
                <pub-id pub-id-type="pmid">18485258</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.woodward.2003.15">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Woodward</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cundall</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Surtees</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winter</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malcolm</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Complex chromosomal rearrangement and associated counseling issues in a family with Pelizaeus-Merzbacher disease.</article-title>
                <source>Am J Med Genet</source>
                <volume>118A</volume>
                <fpage>15</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">12605435</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.woodward.1998a.a394">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Woodward</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kendall</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vetrie</surname>
                    <given-names>D</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>1998a</year>
                <article-title>Variation in PLP gene duplications causing Pelizaeus-Merzbacher disease.</article-title>
                <source>Am J Hum Genet</source>
                <volume>63</volume>
                <fpage>A394</fpage>
              </element-citation>
            </ref>
            <ref id="pmd.REF.woodward.1998b.207">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Woodward</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kendall</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vetrie</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malcolm</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1998b</year>
                <article-title>Pelizaeus-Merzbacher disease: identification of Xq22 proteolipid-protein duplications and characterization of breakpoints by interphase FISH.</article-title>
                <source>Am J Hum Genet</source>
                <volume>63</volume>
                <fpage>207</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">9634530</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.woodward.2000.449">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Woodward</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirtland</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dlouhy</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raskind</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malcolm</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abeliovich</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>X inactivation phenotype in carriers of Pelizaeus-Merzbacher disease: skewed in carriers of a duplication and random in carriers of point mutations.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>8</volume>
                <fpage>449</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">10878666</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.woodward.1999.266">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Woodward</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rao</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malcolm</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Prenatal diagnosis by FISH in a family with Pelizaeus-Merzbacher disease caused by duplication of PLP gene.</article-title>
                <source>Prenat Diagn</source>
                <volume>19</volume>
                <fpage>266</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10210128</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.woodward.2005.966">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Woodward</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cundall</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperle</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sistermans</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howell</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gribble</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burford</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>NP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hobson</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garbern</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamholz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heng</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodes</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malcolm</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hobson</surname>
                    <given-names>GM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Heterogeneous duplications in patients with Pelizaeus-Merzbacher disease suggest a mechanism of coupled homologous and nonhomologous recombination.</article-title>
                <source>Am J Hum Genet</source>
                <volume>77</volume>
                <fpage>966</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">16380909</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.yamada.1999.2143">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ivanova</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamaguchi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lees</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikenaka</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Proteolipid protein gene product can be secreted and exhibit biological activity during early development.</article-title>
                <source>J Neurosci</source>
                <volume>19</volume>
                <fpage>2143</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">10066267</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.yool.2000.987">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yool</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edgar</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montague</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malcolm</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>The proteolipid protein gene and myelin disorders in man and animal models.</article-title>
                <source>Hum Mol Genet</source>
                <volume>9</volume>
                <fpage>987</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">10767322</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="pmd.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="pmd.Suggested_Reading.reflist0">
            <ref id="pmd.REF.duncan.2005.204">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Duncan</surname>
                    <given-names>ID</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>The PLP mutants from mouse to man.</article-title>
                <source>J Neurol Sci</source>
                <volume>228</volume>
                <fpage>204</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15694207</pub-id>
              </element-citation>
            </ref>
            <ref id="pmd.REF.hudson">
              <mixed-citation publication-type="book">Hudson LD. Pelizaeus-Merzbacher disease and the allelic disorder X-linked spastic paraplegia type 2. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID)</italic>. Chap 228. New York, NY: McGraw-Hill. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/">online</ext-link>.</mixed-citation>
            </ref>
            <ref id="pmd.REF.koeppen.2005.198">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koeppen</surname>
                    <given-names>AH</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>A brief history of Pelizaeus-Merzbacher disease and proteolipid protein.</article-title>
                <source>J Neurol Sci</source>
                <volume>228</volume>
                <fpage>198</fpage>
                <lpage>200</lpage>
                <pub-id pub-id-type="pmid">15694205</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="pmd.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="pmd.Acknowledgments">
          <title>Acknowledgments</title>
          <p>The authors are grateful to the PMD Foundation, the Children's Research Center of Michigan, the Nemours Foundation, the NIH, and the PMD families.</p>
        </sec>
        <sec id="pmd.Author_History">
          <title>Author History</title>
          <p>James Y Garbern, MD, PhD; University of Rochester Medical Center (1999-2011*)Grace M Hobson, PhD (2006-present)John Kamholz, MD, PhD (2013-present)Karen Krajewski, MS; Wayne State University School of Medicine/Detroit Medical Center (2006-2010)</p>
          <p>*James Y Garbern was a specialist in leukodystrophies and hereditary neurologic disorders and an internationally recognized expert on PMD. Dr Garbern died in November 2011.</p>
        </sec>
        <sec id="pmd.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>28 February 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>16 March 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>15 September 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>7 October 2004 (jg) Revision: Table 3</p>
            </list-item>
            <list-item>
              <p>11 June 2004 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>20 March 2002 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>15 June 1999 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>28 January 1999 (jg) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
